EGFR and cervical carcinoma: TACC3 was previously suggested to piay a vital role in epidermal growth factor (EGF) mediated EMT, which represents a promising therapeutic strategy for the treatment of cervical carcinoma and is involved in the EGF/EGF receptor (EGFR) signal transduction pathway (Ha et al. 2013c).